250 related articles for article (PubMed ID: 7593131)
1. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
Oda Y; Walter H; Radig K; Röse I; Neumann W; Roessner A
J Cancer Res Clin Oncol; 1995; 121(11):667-73. PubMed ID: 7593131
[TBL] [Abstract][Full Text] [Related]
2. [Association of nm23-H1 with orthopedic oncological conditions].
Ha L; Guo W; Feng C; Li H
Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):477-9. PubMed ID: 11825445
[TBL] [Abstract][Full Text] [Related]
3. Expression of nm23 protein in human osteosarcoma in relationship with early metastasis.
Liao WM; Chiu KY; Li FB; Qiu JS; Han SY; Chow SP
Orthopedics; 2000 Nov; 23(11):1175-8. PubMed ID: 11103961
[TBL] [Abstract][Full Text] [Related]
4. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
5. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
6. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic proteins and receptors in sarcomas.
Guo W; Gorlick R; Ladanyi M; Meyers PA; Huvos AG; Bertino JR; Healey JH
Clin Orthop Relat Res; 1999 Aug; (365):175-83. PubMed ID: 10627702
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
9. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA
J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
[TBL] [Abstract][Full Text] [Related]
10. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
[No Abstract] [Full Text] [Related]
11. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.
Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P
Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120
[TBL] [Abstract][Full Text] [Related]
12. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
13. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.
Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST
Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
15. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
16. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
17. Experimental therapies and clinical trials in bone sarcoma.
Chugh R
J Natl Compr Canc Netw; 2010 Jun; 8(6):715-25. PubMed ID: 20581301
[TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
19. Sarcomas of bone in childhood: pathologic aspects.
Kissane JM; Askin FB; Nesbit ME; Vietti TJ; Burgert EO; Cangir A; Gehan EA; Perez CA; Pritchard DJ; Tefft M
Natl Cancer Inst Monogr; 1981 Apr; (56):29-41. PubMed ID: 6272116
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]